The COVID-19 pandemic has had an acute impact on the private equity deal environment and the broader global economy.

The UK's new corporate offence of failure to prevent facilitation of tax evasion is quite a mouthful, but the title does do a pretty accurate job of describing the offence.

Over the last few months, most of the attention in the climate space in the U.S. has been on the dramatic, and expected, shift in federal government policy.

A recurring topic of discussion among secondaries market players is the extent to which the growth in GP-led deal volume in recent years has primarily resulted from transitory factors, such as softness in exit markets.

This week, the U.S. Department of Justice and Drug Enforcement Administration announced a $35 million settlement with a major pharmaceutical manufacturer to resolve alleged failures to monitor and report...

Recent weeks have seen two significant developments with respect to federal and state laws regulating financial interactions between pharmaceutical and medical device companies and health care providers.

On May 20, 2019, the U.S. Supreme Court issued an 8-1 ruling in the case of Mission Product Holdings, Inc. v. Tempnology, LLC.

Significantly, pending completion of its study, the IRS will entertain private letter ruling requests on the issues described in the announcement.

As we head into the fourth quarter of what has already been a busy year in the secondaries market, we wanted to revisit a topic from the summer that may impact sales activity: the endowment tax regime.

On September 29, 2025, the SEC issued a notice relating to an amended application filed by DFA Investment Dimensions Group Inc., et al., ("DFA") for an exemptive order that would permit registered open-end funds...

Every month, our attorneys publish articles, alerts, white papers, blog posts and podcasts on a wide range of ESG, CSR and business and human rights topics.

The Federal Trade Commission has announced an amendment to the premerger notification rules under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "Act"), which will require increased reporting of transfers of patent rights in the pharmaceutical industry.

SEC Rule 14a-8, the shareholder proposal rule, allows a shareholder who's owned at least $2,000 worth of company stock for at least one year to have a proposal included in the company's proxy...

On August 21, the US and EU announced that they have agreed on a Framework on an Agreement on Reciprocal, Fair, and Balanced Trade.

In this Ropes & Gray podcast, asset management partner Mike Doherty and counsel Laura Hirst discuss the 2009 Term Asset-Backed Securities Loan Facility (TALF) program which the Fed..

Many of the provisions of the final rule will take effect in January 2018.

On October 2, 2014, the Food and Drug Administration ("FDA") released the final version of a guidance document entitled, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices."

The new tax applies to individuals, estates and trusts with unearned "net investment income" in excess of certain amounts.

In this Ropes & Gray podcast, asset management partners Melissa Bender and Isabel Dische discuss the recently published revised edition of the UK Stewardship Code. In particular...

In a move to support British innovative industry, Sam Gyimah, the UK IP Minister, announced today, April 26, 2018, that the UK has ratified the UPC Agreement, making it the sixteenth country...